Cargando…

Effect of cervus and cucumis polypeptide combined with zoledronic acid on bone metabolic biochemical markers in glucocorticoids – Induced osteoporosis patients

OBJECTIVE: To investigate the effect of cervus and cucumis polypeptide combined with zoledronic acid on bone metabolic biochemical markers in glucocorticoids - induced osteoporosis patients. METHODS: A total of 100 patients with glucocorticoids - induced osteoporosis admitted to our hospital from Ja...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Dacheng, Long, Anhua, Wang, Jialong, Wang, Xuefei, Zhang, Yakui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600785/ https://www.ncbi.nlm.nih.gov/pubmed/31303836 http://dx.doi.org/10.1016/j.sjbs.2019.04.010

Ejemplares similares

Improved Calculation Method of TAD for Intertrochanteric Fractures
por: Wang, Jialong, et al.
Publicado: (2022)

Effect of Cervus and Cucumis Peptides on Osteoblast Activity and Fracture Healing in Osteoporotic Bone
por: Wang, Ai-Yuan, et al.
Publicado: (2014)

The impact of perioperative glucose variability on outcomes after hip fracture
por: Long, Anhua, et al.
Publicado: (2022)

Cervus and cucumis peptides ameliorates bone erosion in experimental arthritis by inhibiting osteoclastogenesis
por: Lin, Ze-Min, et al.
Publicado: (2019)

The effectiveness and safety of cervus and cucumis polypeptide injection in promoting fracture healing after bone fracture surgeries: Protocol for a systematic review and meta-analysis
por: Yang, Xia, et al.
Publicado: (2019)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis
por: Qi, Tao, et al.
Publicado: (2020)

Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis
por: Jiang, Yan, et al.
Publicado: (2015)

Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study
por: Dito, Giorgia, et al.
Publicado: (2023)

Clinical effect of Zoledronic Acid in the treatment of Senile Osteoporosis
por: Kong, Li, et al.
Publicado: (2020)

Effect of pilose antler polypeptide on the mechanism of bone homeostasis in osteoporosis
por: Wang, Guochen, et al.
Publicado: (2023)

Assessment of biochemical bone markers of osteoporosis in children with thalassemia major
por: Çelik, Tanju, et al.
Publicado: (2022)

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
por: Farahmand, P., et al.
Publicado: (2013)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
por: Hamdy, Ronald C
Publicado: (2010)

How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011)

Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010)

Biochemical Bone Turnover Markers and Osteoporosis in Older Men: Where Are We?
por: Szulc, Pawel
Publicado: (2011)

Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid
por: Kasai, Hidefumi, et al.
Publicado: (2020)

Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women
por: Chao, Ma, et al.
Publicado: (2013)

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Piper, Paul K, et al.
Publicado: (2009)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Development of Diagnostic SNP Markers To Monitor Hybridization Between Sika Deer (Cervus nippon) and Wapiti (Cervus elaphus)
por: Ba, Hengxing, et al.
Publicado: (2018)

Curative Effect of Prebiotics/Probiotics Preparations Combined with Zoledronic Acid + Calcitriol Regimen on Patients with Primary Osteoporosis and Their Influences on Bone Metabolism Markers
por: Jia, Ruipeng, et al.
Publicado: (2022)

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
por: Alcaraz, A, et al.
Publicado: (2013)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
por: Lu, Yanhui, et al.
Publicado: (2013)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Antiosteoporosis and bone protective effect of dieckol against glucocorticoid-induced osteoporosis in rats
por: Wang, Hao, et al.
Publicado: (2022)

Comparison of the effects of canola oil versus sunflower oil on the biochemical markers of bone metabolism in osteoporosis
por: Azemati, Mahbobe, et al.
Publicado: (2012)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker
por: Mori, Y., et al.
Publicado: (2018)

Uncovering the Fecal Bacterial Communities of Sympatric Sika Deer (Cervus nippon) and Wapiti (Cervus canadensis)
por: Yan, Jiakuo, et al.
Publicado: (2022)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009)

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate - A Case Report -
por: Seok, Hyun, et al.
Publicado: (2011)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
por: Ringe, Johann D
Publicado: (2010)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis
por: Al-Agha, Abdulmoein E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r5udu6vphgl2af3thf0krsjivq